Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing

Sara B Griesemer, Greta Van Slyke, Dylan Ehrbar, Klemen Strle, Tugba Yildirim, Dominick A Centurioni, Anne C Walsh, Andrew K. Chang, Michael J Waxman, Kirsten St. George
doi: https://doi.org/10.1101/2020.06.16.20133041
Sara B Griesemer
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greta Van Slyke
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dylan Ehrbar
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klemen Strle
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tugba Yildirim
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominick A Centurioni
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne C Walsh
2Directors Office, Wadsworth Center, New York State Department of Health, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew K. Chang
3Department of Emergency Medicine, Albany Medical Center, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J Waxman
3Department of Emergency Medicine, Albany Medical Center, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten St. George
1Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY
4Department of Biomedical Sciences, School of Public Health, University at Albany, SUNY, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Kirsten.St.George@health.ny.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Identifying SARS-CoV-2 infections through aggressive diagnostic testing remains critical in tracking and curbing the spread of the COVID-19 pandemic. Collection of nasopharyngeal swabs (NPS), the preferred sample type for SARS-CoV-2 detection, has become difficult due to the dramatic increase in testing and consequential supply strain. Therefore, alternative specimen types have been investigated, that provide similar detection sensitivity with reduced health care exposure and potential for self-collection. In this study, the detection sensitivity of SARS-CoV-2 in nasal swabs (NS) and saliva was compared to that of NPS, using matched specimens from two outpatient cohorts in New York State (total n = 463). The first cohort showed only a 5.4% positivity but the second cohort (n=227) had a positivity rate of 41%, with sensitivity in NPS, NS and saliva of 97.9%, 87.1%, and 87.1%, respectively. Whether the reduced sensitivity of NS or saliva is acceptable must be assessed in the settings where they are used. However, we sought to improve on it by validating a method to mix the two sample types, as the combination of nasal swab and saliva resulted in 94.6% SARS-CoV-2 detection sensitivity. Spiking experiments showed that combining them did not adversely affect the detection sensitivity in either. Virus stability in saliva was also investigated, with and without the addition of commercially available stabilizing solutions. The virus was stable in saliva at both 4°C and room temperature for up to 7 days. The addition of stabilizing solutions did not enhance stability and in some situations reduced detectable virus levels.

Competing Interest Statement

SBG, GVS, DE, TY, DAC, ACW, AKC, and MJW declare no conflict of interest. KS has served as a paid consultant for T2 Biosystems and Roche Diagnostics. KSG receives research support from ThermoFisher for the evaluation of new assays for the diagnosis and characterization of viruses, including SARS-CoV-2. She also has a royalty generating collaborative agreement with Zeptometrix.

Funding Statement

This project was performed with internal funding from the New York State Department of Health and Albany Medical Center.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was granted non-research determination under the emergency response criterion by the New York State Department of Health Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors declare that data that support the findings of this study are available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
Sara B Griesemer, Greta Van Slyke, Dylan Ehrbar, Klemen Strle, Tugba Yildirim, Dominick A Centurioni, Anne C Walsh, Andrew K. Chang, Michael J Waxman, Kirsten St. George
medRxiv 2020.06.16.20133041; doi: https://doi.org/10.1101/2020.06.16.20133041
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
Sara B Griesemer, Greta Van Slyke, Dylan Ehrbar, Klemen Strle, Tugba Yildirim, Dominick A Centurioni, Anne C Walsh, Andrew K. Chang, Michael J Waxman, Kirsten St. George
medRxiv 2020.06.16.20133041; doi: https://doi.org/10.1101/2020.06.16.20133041

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8550)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1744)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10281)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1670)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (247)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1764)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)